The experimental observation herein reported indicates that miR-4432 targets FGFBP1 in human ECs, representing a novel potential strategy against numerous diseases characterized by endothelial dysfunction, including hypertension [24,25,26,27,28,29]. Here, FGFBP1 is linked to hypertensive disorder.